Inactive Instrument

Global Cord Blood Corp Share Price Nyse

Equities

KYG211071009

Healthcare Facilities & Services

Financials

Sales 2021 1.16B 161M 12.8B Sales 2022 1.24B 172M 13.73B Capitalization 2.97B 411M 32.76B
Net income 2021 508M 70.39M 5.61B Net income 2022 501M 69.42M 5.53B EV / Sales 2021 -2.13 x
Net cash position 2021 6.07B 842M 67.06B Net cash position 2022 6.66B 923M 73.53B EV / Sales 2022 -2.97 x
P/E ratio 2021
7.1 x
P/E ratio 2022
5.93 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 38.41%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 52 31/12/08
Director of Finance/CFO 48 31/12/08
Chief Tech/Sci/R&D Officer 70 31/10/04
Members of the board TitleAgeSince
Director/Board Member 56 31/12/08
Chief Executive Officer 52 31/12/08
Director/Board Member 56 31/12/08
More insiders
Global Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.
More about the company